Chugh Savneek, Kichloo Asim, Jafri Firas, Yusvirazi Liga, Lerner Robert
New York Medical College, Valhalla, NY, USA.
Central Michigan University, St Mary's Hospital, Saginaw, MI, USA.
J Investig Med High Impact Case Rep. 2017 Sep 22;5(3):2324709617732797. doi: 10.1177/2324709617732797. eCollection 2017 Jul-Sep.
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consumptive thrombocytopenia, and microangiopathic hemolytic anemia, leading to end-organ ischemia and infarction, affecting particularly the kidney and brain. TMA is a pathological feature of a number of clinical disorders including thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and atypical hemolytic uremic syndrome. Rare but important, TMA may also occur in malignancy, connective tissue disease, malignant hypertension, and renal transplantation (rejection or drug toxicity). We present a very rare case where the patient developed acute kidney injury from TMA but found to have multiple myeloma as the possible underlying etiology.
血栓性微血管病(TMA)描述了一种微血管血栓形成、消耗性血小板减少和微血管病性溶血性贫血的病理过程,可导致终末器官缺血和梗死,尤其影响肾脏和大脑。TMA是多种临床疾病的病理特征,包括血栓性血小板减少性紫癜、溶血性尿毒症综合征和非典型溶血性尿毒症综合征。虽然罕见但很重要的是,TMA也可能发生于恶性肿瘤、结缔组织病、恶性高血压和肾移植(排斥反应或药物毒性)。我们报告了一例非常罕见的病例,该患者因TMA发生急性肾损伤,但发现可能的潜在病因是多发性骨髓瘤。